Benzinga | Jul 13, 2021 08:11AM EDT

Vivos Therapeutics, Inc. Announces Results From Study Commissioned By Co. Showing 28% Of Patients Treated With Co.'s DNA Appliance Reported No Remaining OSA Symptoms